New HBF boss warns private hospitals to reduce profits
Por um escritor misterioso
Descrição
HBF appoints hospital boss Lachlan Henderson as next CEO to lead
Crispr Therapeutics AG - 10K - Annual Report - February 21, 2023
SEC Filing CRISPR Therapeutics
The Lancet Global Health Commission on Global Eye Health: vision
2023-11-07 (Tu) EWC_Cyberdeck Enclosure design and failed cuts
Investment returns propel HBF to $17.7m surplus
Bellow Press - Previous Editions of Workplaces Magazine and The
ACCC warns of higher health insurance premiums as inflation bites
Arthur-Owens-page-2
Lifeboat Foundation News Blog: Author Omuterema Akhahenda
It's an ugly year in health care': Hospitals report record losses
HBF set to unveil details of near $100 million pandemic return to
10-K
SEC Filing Sangamo Therapeutics, Inc.
SEC Filing Beam Therapeutics
de
por adulto (o preço varia de acordo com o tamanho do grupo)
